Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

January 3, 2002

Primary Completion Date

December 18, 2003

Study Completion Date

December 22, 2003

Conditions
Major Depressive Disorder
Interventions
DRUG

aprepitant

DRUG

Comparator: placebo (unspecified)

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00048594 - Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED) | Biotech Hunter | Biotech Hunter